Screener
Biogen BIIB Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Biogen in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.
The source filing: Biogen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 6:36 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000875045-26-000075
| Line item | As of June 30, 2026 | As of December 31, 2025 |
|---|---|---|
| Accounts receivable, net of allowance for doubtful accounts of $2.9 and $3.0, respectively | 1,885.6 | 1,342.4 |
| Due from anti-CD20 therapeutic programs | 512.8 | 524.6 |
| Inventory | 2,384.3 | 2,168.1 |
| Other current assets | 1,238.0 | 1,123.3 |
| Total current assets | 7,305.7 | 8,974.1 |
| Marketable securities | — | 431.9 |
| Property, plant and equipment, net | 2,994.1 | 3,055.4 |
| Operating lease assets | 245.7 | 265.4 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Biogen's prepaid & other current?
- Biogen (BIIB) reported prepaid & other current of $1.24B in Q2 2026.
- How has Biogen's prepaid & other current changed year-over-year?
- Biogen's prepaid & other current increased by 45.5% year-over-year, from $850.6M to $1.24B.
- What is the long-term trend for Biogen's prepaid & other current?
- Over 5 years (2020 to 2025), Biogen's prepaid & other current has grown at a 5.0% compound annual growth rate (CAGR), from $881.1M to $1.12B.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Biogen's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude